FDA Inspection 1287036 — Khaldoun Ben Hamda MD
The FDA completed an inspection of Khaldoun Ben Hamda MD on September 5, 2025 in Monastir. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 5, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Monastir (Tunisia)
Additional Details
Clinical Investigator (CI)